Efficacy and safety of a once-yearly i.v
β
Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler;
π
Article
π
2010
π
American Society for Bone and Mineral Research
π
English
β 216 KB
## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a onceβyearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi